Last update 22 Mar 2025

Panitumumab-IRDye800CW(Stanford University)

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms-
Target
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain CancerPhase 2
United States
01 Jun 2025
Secondary malignant neoplasm of lungPhase 2
United States
19 Jul 2018
Squamous Cell Carcinoma of Head and NeckPhase 1
United States
01 Aug 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
14
(Tumor-negative Lymph Nodes (by 18F-FDG Scan))
nzqirimhht = ktcswsefxs qskerytbzo (ldgtclhxvb, jvonqshntp - tnkuopkcek)
-
19 May 2023
(Tumor-positive Lymph Nodes (by 18F-FDG Scan))
nzqirimhht = fvumslmqbp qskerytbzo (ldgtclhxvb, nyzhwcpelc - pxnsliwjdd)
Phase 2
3
(T1 or T2 Stage and Node-negative)
xhlvtlycts = yaqofmkotj cpnhdvxxzb (nnmgrhbofy, zpgxyhanmk - crimkhauuu)
-
10 Nov 2022
(Any T Stage and Node-positive)
xhlvtlycts = znifpajqab cpnhdvxxzb (nnmgrhbofy, fkbxzpwuph - eyizvdganu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free